339 related articles for article (PubMed ID: 7927499)
1. Antigen-presenting capacity of rheumatoid synovial fibroblasts.
Boots AM; Wimmers-Bertens AJ; Rijnders AW
Immunology; 1994 Jun; 82(2):268-74. PubMed ID: 7927499
[TBL] [Abstract][Full Text] [Related]
2. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
4. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
5. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation.
Kraft M; Filsinger S; Krämer KL; Kabelitz D; Hänsch GM; Schoels M
Immunology; 1995 Jul; 85(3):461-6. PubMed ID: 7558136
[TBL] [Abstract][Full Text] [Related]
6. Recognition of rheumatoid arthritis synovial antigen by CD4+,CD8- T cell clones established from rheumatoid arthritis joints.
Toyosaki T; Tsuruta Y; Yoshioka T; Takemoto H; Suzuki R; Tomita T; Ochi T
Arthritis Rheum; 1998 Jan; 41(1):92-100. PubMed ID: 9433874
[TBL] [Abstract][Full Text] [Related]
7. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
[TBL] [Abstract][Full Text] [Related]
8. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
Waalen K; Førre O; Teigland J; Natvig JB
Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
[TBL] [Abstract][Full Text] [Related]
9. The effect of cytokines on the expression of MHC antigens and ICAM-1 by normal and transformed synoviocytes.
Wicks IP; Leizer T; Wawryk SO; Novotny JR; Hamilton J; Vitti G; Boyd AW
Autoimmunity; 1992; 12(1):13-9. PubMed ID: 1352152
[TBL] [Abstract][Full Text] [Related]
10. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
Spurrell DR; Oldford SA; Frost T; Larsen B; Codner D; Edgecombe A; Drover S
Hum Immunol; 2004 Dec; 65(12):1516-29. PubMed ID: 15603880
[TBL] [Abstract][Full Text] [Related]
11. Dissection of defective antigen presentation by interferon-gamma-treated fibroblasts.
Geppert TD; Lipsky PE
J Immunol; 1987 Jan; 138(2):385-92. PubMed ID: 3098840
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation by Hodgkin's disease cells.
Fisher RI; Cossman J; Diehl V; Volkman DJ
J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Ia antigens by rheumatoid synovial lining cells.
Burmester GR; Jahn B; Rohwer P; Zacher J; Winchester RJ; Kalden JR
J Clin Invest; 1987 Sep; 80(3):595-604. PubMed ID: 2442194
[TBL] [Abstract][Full Text] [Related]
14. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
15. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
Rhodes J; Tite J
J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
[TBL] [Abstract][Full Text] [Related]
16. Dissection of the antigen presenting function of tissue cells induced to express HLA-DR by gamma interferon.
Geppert TD; Lipsky PE
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():59-62. PubMed ID: 3112378
[TBL] [Abstract][Full Text] [Related]
17. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.
Malone DG; Wahl SM; Tsokos M; Cattell H; Decker JL; Wilder RL
J Clin Invest; 1984 Oct; 74(4):1173-85. PubMed ID: 6384266
[TBL] [Abstract][Full Text] [Related]
18. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
19. Presence of HLA-DR antigen on synovial type A and B cells: an immunoelectron microscopic study in rheumatoid arthritis, osteoarthritis and normal traumatic joints.
Shiozawa S; Shiozawa K; Fujita T
Immunology; 1983 Dec; 50(4):587-94. PubMed ID: 6581119
[TBL] [Abstract][Full Text] [Related]
20. Quantification of macrophage cell surface molecules in rheumatoid arthritis.
Hessian PA; Highton J; Palmer DG
Clin Exp Immunol; 1989 Jul; 77(1):47-51. PubMed ID: 2527651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
